Trial intelligence / Profile preview

Transmural Collaborative Care with duloxetine for depression and subchronic or chronic pain

NL-OMON26763Recruiting

Sponsor
Trimbos Institute
Start
Sep 2007
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of duloxetine and Placebo-COD Research Private Ltd in major depressive disorder (MDD), subthreshold depression (sD) and chronic pain (3 arms), sponsored by Trimbos Institute. Primary endpoint: Depression severity. Started Sep 2007; status: recruiting.

02

Drugs

duloxetinePlacebo-COD Research Private Ltd
03

Conditions

major depressive disorder (MDD)subthreshold depression (sD)chronic pain

Beyond the preview

Go deeper on NL-OMON26763.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON26763.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call